Back
Pulmonx 10K Form
Sell
47
LUNG
Pulmonx
Last Price:
6.12
Seasonality Move:
9.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-15 | 10K | LUNG/Pulmonx Annual |
| 2020-11-13 | 10Q | LUNG/Pulmonx Quarterly |
Receive LUNG News And Ratings
See the #1 stock for the next 7 days that we like better than LUNG
LUNG Financial Statistics
Sales & Book Value
| Annual Sales: | $68.68M |
|---|---|
| Cash Flow: | $-7.66M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.38 |
| Price / Book: | 2.54 |
Profitability
| EPS (TTM): | -1.47000 |
|---|---|
| Net Income (TTM): | $-57.11M |
| Gross Margin: | $50.75M |
| Return on Equity: | -51.95% |
| Return on Assets: | -32.92% |
Pulmonx Earnings Forecast
Key Pulmonx Financial Ratios
- The Gross Profit Margin over the past 6 years for LUNG is 73.90%.
- The Selling, General & Administrative Expenses for LUNG have been equal to 137.76% of Gross Profit Margin.
- The Research & Development expenses have been 26.33% of Revenue.
- The Interest Expense is -5.31% of Operating Income.
- The Net Earning history of LUNG is -88.60% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 1 years.
Pulmonx Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | LUNG |
| CUSIP: | 745848 |
| Website: | pulmonx.com |
Debt
| Debt-to-Equity Ratio: | 0.4 |
|---|---|
| Current Ratio: | 7.7 |
| Quick Ratio: | 6.56 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |